
SEC receives amended S-1/A filing for 21Shares Injective ETF as altcoin ETF race heats up
The SEC's review of the 21Shares Injective ETF could accelerate mainstream adoption of altcoins, impacting market dynamics and investor strategies.
- neutral toward SEC · 94%


















